Skip to main content
. 2021 Jan 12;11:746. doi: 10.1038/s41598-020-80608-3

Figure 4.

Figure 4

(A) Cell viability evaluation of CHAS with drugs (i.e., BMP-2 and/or ALN) using CCK-8 assay on osteoblasts. (B) ALP activity of osteoblasts in CHAS depending on the drugs (i.e., BMP-2 and/or ALN).